Cargando…

GLP-1 receptor signaling increases PCSK1 and β cell features in human α cells

Glucagon-like peptide-1 (GLP-1) is an incretin hormone that potentiates glucose-stimulated insulin secretion. GLP-1 is classically produced by gut L cells; however, under certain circumstances α cells can express the prohormone convertase required for proglucagon processing to GLP-1, prohormone conv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saikia, Mridusmita, Holter, Marlena M., Donahue, Leanne R., Lee, Isaac S., Zheng, Qiaonan C., Wise, Journey L., Todero, Jenna E., Phuong, Daryl J., Garibay, Darline, Coch, Reilly, Sloop, Kyle W., Garcia-Ocana, Adolfo, Danko, Charles G., Cummings, Bethany P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934853/ https://www.ncbi.nlm.nih.gov/pubmed/33554958 http://dx.doi.org/10.1172/jci.insight.141851

Ejemplares similares

14-3-3-zeta mediates GLP-1 receptor agonist action to alter α cell proglucagon processing
por: Holter, Marlena M., et al.
Publicado: (2022)

Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion
por: Holter, Marlena M., et al.
Publicado: (2022)

β Cell GLP-1R Signaling Alters α Cell Proglucagon Processing after Vertical Sleeve Gastrectomy in Mice
por: Garibay, Darline, et al.
Publicado: (2018)

The 7-α-dehydroxylation pathway: An integral component of gut bacterial bile acid metabolism and potential therapeutic target
por: Wise, Journey L., et al.
Publicado: (2023)

Compound 18 Improves Glucose Tolerance in a Hepatocyte TGR5-dependent Manner in Mice
por: Holter, Marlena M., et al.
Publicado: (2020)

Exploring the Relationship Between Bariatric Surgery and Inflammatory Bowel Disease: A Systematic Review
por: Wise, Journey, et al.
Publicado: (2022)

TGR5 Signaling in Hepatic Metabolic Health
por: Holter, Marlena M., et al.
Publicado: (2020)

Vertical sleeve gastrectomy reduces blood pressure and hypothalamic endoplasmic reticulum stress in mice
por: McGavigan, Anne K., et al.
Publicado: (2017)

Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment
por: Chodorge, Matthieu, et al.
Publicado: (2018)

Deoxycholic acid supplementation impairs glucose homeostasis in mice
por: Zaborska, Karolina E., et al.
Publicado: (2018)

Congenital hemihyperplasia with hemipigmentation: A rare presentation
por: Arora, Major Vishal, et al.
Publicado: (2015)

GLP-1 and Intestinal Diseases
por: Hunt, Jenna Elizabeth, et al.
Publicado: (2021)

Codon optimality controls differential mRNA translation during amino acid starvation
por: Saikia, Mridusmita, et al.
Publicado: (2016)

Simultaneous multiplexed amplicon sequencing and transcriptome profiling in single cells
por: Saikia, Mridusmita, et al.
Publicado: (2018)

Proposal of New Key Step in Lateral Approach Thyroidectomy in Light of Comparison of Surgical Outcomes of Medial versus Lateral Approach Thyroidectomy: A Randomised Controlled Study
por: Phookan, Jyotirmoy, et al.
Publicado: (2021)

FOURIER & PCSK9 RNAi: Towards enhancing durability and efficacy of PCSK9 inhibitors
por: Hassan, Mohamed
Publicado: (2017)

The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017)

Identification of recognition residues for ligation-based detection and quantitation of pseudouridine and N(6)-methyladenosine
por: Dai, Qing, et al.
Publicado: (2007)

The Multifaceted Biology of PCSK9
por: Seidah, Nabil G, et al.
Publicado: (2021)

A Novel Humanized GLP-1 Receptor Model Enables Both Affinity Purification and Cre-LoxP Deletion of the Receptor
por: Jun, Lucy S., et al.
Publicado: (2014)

Correction: A Novel Humanized GLP-1 Receptor Model Enables Both Affinity Purification and Cre-LoxP Deletion of the Receptor
por: Jun, Lucy S., et al.
Publicado: (2015)

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
por: Willard, Francis S., et al.
Publicado: (2020)

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist
por: Kawai, Takahiro, et al.
Publicado: (2020)

Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study
por: Ko, Dennis T., et al.
Publicado: (2018)

The effect of PCSK9 immunization on the hepatic level of microRNAs associated with the PCSK9/LDLR pathway
por: Ataei, Sarina, et al.
Publicado: (2023)

Novel agonist and antagonist radioligands for the GLP‐2 receptor. Useful tools for studies of basic GLP‐2 receptor pharmacology
por: Gadgaard, Sarina, et al.
Publicado: (2022)

PCSK9 Antibodies for the Treatment of Hypercholesterolemia
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2014)

PCSK9 and Atherosclerosis - Lipids and Beyond
por: Shapiro, Michael D., et al.
Publicado: (2017)

An Update on the Role of PCSK9 in Atherosclerosis
por: Yurtseven, Ece, et al.
Publicado: (2020)

Autocrine effects of PCSK9 on cardiomyocytes
por: Wolf, Annemarie, et al.
Publicado: (2020)

Naturally Occurring PCSK9 Inhibitors
por: Adorni, Maria Pia, et al.
Publicado: (2020)

PCSK9 Monoclonal Antibodies: An Overview
por: Kaddoura, Rasha, et al.
Publicado: (2020)

Pleiotropic Effects of PCSK-9 Inhibitors
por: Basiak, Marcin, et al.
Publicado: (2021)

Phage display for targeting PCSK9
por: Ferri, Nicola
Publicado: (2021)

Insight into the Evolving Role of PCSK9
por: Maligłówka, Mateusz, et al.
Publicado: (2022)

Gene Therapy Targeting PCSK9
por: Katzmann, Julius L., et al.
Publicado: (2022)

PCSK9 as an Atherothrombotic Risk Factor
por: Sotler, Tadeja, et al.
Publicado: (2023)

Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly
por: Holla, Øystein L, et al.
Publicado: (2007)

Internalized PCSK9 dissociates from recycling LDL receptors in PCSK9-resistant SV-589 fibroblasts
por: Nguyen, My-Anh, et al.
Publicado: (2014)

Biochemical and Genetic Characterization of PspE and GlpE, Two Single-domain Sulfurtransferases of Escherichia coli
por: Cheng, Hui, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_rk6f3kcju8ahhhr93o4m2pkaho